Shenzhen Capchem Technology (300037) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
20 Aug, 2026Executive summary
Revenue for H1 2026 reached ¥7.46 billion, up 75.66% year-over-year, with net profit attributable to shareholders at ¥983.81 million, up 103.33% year-over-year. Major growth was driven by battery chemicals and electronic information chemicals, while organic fluorine chemicals saw a slight decline.
The company maintained strong R&D investment, expanded global production capacity, and continued to deepen strategic customer relationships. Key projects and capacity expansions in battery chemicals and high-end fluorine materials progressed as planned.
Financial highlights
Operating income: ¥7.46 billion, up 75.66% year-over-year.
Net profit attributable to shareholders: ¥983.81 million, up 103.33% year-over-year.
Operating cash flow: ¥1.13 billion, up 97.93% year-over-year.
Basic EPS: ¥1.31, up 104.69% year-over-year.
Gross margin for battery chemicals: 15.32%; electronic information chemicals: 51.68%; organic fluorine chemicals: 55.87%.
Outlook and guidance
The company expects continued growth in battery chemicals, driven by demand in new energy vehicles and energy storage.
Organic fluorine chemicals are positioned for future growth as new applications in semiconductors and digital infrastructure mature.
Ongoing global expansion and vertical integration are expected to enhance supply chain resilience and cost competitiveness.
Latest events from Shenzhen Capchem Technology
- Q1 2026 saw revenue up 67.85% and net profit up 109.02% year-over-year.300037
Q1 2026 - Q3 2025 revenue up 13.6%, net profit down 7.5%, with strong cash flow and higher R&D spend.300037
Q3 2025 - H1 2025 revenue up 18.58%, net profit up 16.36%, with strong growth across all segments.300037
Q2 2025 - YTD net profit fell 12% and operating cash flow turned sharply negative.300037
Q3 2024 - Revenue up 4.35% but net profit down 19.54% as margin pressure persists; global expansion continues.300037
Q2 2024 - Q1 2025 net profit surged 39% year-over-year on strong revenue growth and improved margins.300037
Q1 2025 - Revenue up 4.85%, net profit down 6.83%, strong global expansion and R&D investment.300037
Q4 2024